Deficiency of Alpha-1-Antitrypsin
Quantitative CT as a New Tool for Evaluating COPD in Alpha-1 Antitrypsin Deficiency
For such a rare hereditary disorder as alpha-1 antitrypsin deficiency (AATD), we have so far…
Long-term results of alpha-1-antitrypsin deficiency treatment – RAPID program
RAPID/RAPID Extension is the largest clinical program to date that has confirmed the benefit…
How Common is Alpha-1 Antitrypsin Deficiency?
What is the prevalence of alpha-1 antitrypsin deficiency (AATD)? What comorbidities are…
Impact of Alpha-1 Antitrypsin Deficiency on Quality of Life and Mental Health of Patients
The clinical manifestation of alpha-1 antitrypsin deficiency and its impact on quality of life…
Self-administration of alpha-1-antitrypsin can significantly improve patients' quality of life
Treatment of alpha-1 antitrypsin deficiency (AATD) requires lifetime administration of weekly…
Deficit Alpha-1-Antitrypsin as an Underestimated Problem? What a Survey Among European Experts Revealed
Alpha-1-antitrypsin deficiency (AATD) is a congenital disorder caused by mutations in the…
The Importance of Early Diagnosis and Treatment of AATD in Preventing Pulmonary Emphysema
Alpha-1 antitrypsin deficiency (AATD) is a risk factor for the development of various…
Should We Test for Alpha-1-Antitrypsin in All COPD Patients?
Approximately 1–2% of patients with chronic obstructive pulmonary disease (COPD) have an…
1
2
Subscribe
Conferences news
Go to records
Go to records
Go to records
Go to records
Go to records
Most read on this topic
- Autoimmune Liver Diseases in Children. Part I
- Liver disease at alpha-1-antitrypsin deficiency
- Autoimmune liver diseases in children. Part II
- Rare diseases in the year 2019 – the Czech and international context
- Quantitative CT as a New Tool for Evaluating COPD in Alpha-1 Antitrypsin Deficiency
- Current (and Future) Possibilities for Diagnosing Alpha-1-Antitrypsin Deficiency
Related topic
Interesting links